Accretion Nutraveda Board Approves MOA Alteration, Borrowing Limit Increase

Accretion Nutraveda Ltd announced that its Board of Directors, in a meeting held on September 1, 2026, approved several key proposals. These include the alteration of the Object Clause in the Memorandum of Association (MOA) to expand business activities, particularly in nutraceuticals and pharmaceuticals. The board also approved increasing borrowing limits under Section 180(1)(c) of the Companies Act, 2013, and enhancing limits for creating charges on company property under Section 180(1)(a). Furthermore, proposals for advancing loans, providing guarantees, and making investments exceeding prescribed limits under Sections 185 and 186 were approved. These approvals are subject to shareholder and regulatory clearances.